2 FTSE 100 dividend bargains I’d still buy after they returned 15% in a year

Rupert Hargreaves looks back at two of his top tips from 2018 and explains why he still thinks they’re attractive.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Around this time last year, I picked out two FTSE 100 ‘dividend bargains’ that I thought were undervalued at the time and looked ‘too cheap to pass up’.

Nearly 12 months on and these stocks have gone on to smash the market. My first pick, DS Smith (LSE: SMDS) has produced a return of 15.2% over the past 12 months, outperforming the FTSE 100 by around 5.2%. 

Meanwhile, my second pick, Informa (LSE: INF), returned 13.4%, outperforming the market by 3.4% over the past 12 months. 

Even after these impressive performances, I think these stocks are still undervalued, and today I’m going to explain why I believe this to be the case. 

Booming earnings 

In 2018, DS Smith launched a £1bn rights issue to fund its biggest-ever acquisition. With more shares in issue, the company’s earnings per share fell by around 14% in fiscal 2019, even though net income rose. Costs associated with the acquisition also weighed on reported earnings.

However, the City is expecting the benefits of this acquisition to be fully reflected in the company’s earnings for its current financial year. Analysts believe DS will reveal a 25% increase in earnings per share for fiscal 2020, which puts the stock on a forward price-to-earnings ratio of 10.9. 

This time last year the stock was changing hands for around 9 times forward earnings, so it looks to me as if the market is not giving the company full credit for its progress over the past 12 months. 

On top of this, there’s also DS’s dividend yield. The stock currently yields 4.4%, and the payout is covered 2.1 times by earnings per share. With analysts expecting the yield to hit 4.7% next year, this income champion hasn’t lost any of its appeal over the past 12 months.

Standing still

Shares in business intelligence group Informa look just as attractive as they were this time last year. When I covered the stock at the beginning of December 2018, it was trading at a forward P/E of 15.3.

Today, the multiple is 15.7. Analysts are forecasting earnings growth of 38% for the year, thanks to the benefit of a significant acquisition on Informa’s bottom line.

The group acquired its smaller peer UBM last year, mostly in shares, which increased the share count but has produced synergies across the enlarged business, driving up profit margins. 

One of the things that really impressed me about the company last time I covered the stock was its dividend track record. Over the past two years, its dividend has grown at a compound annual rate of nearly 8%. Analysts are expecting this trend to continue, with dividend growth of 7.1% pencilled in for 2019 and 6% for 2020.

Based on these forecasts, the stock will yield around 3% next year. That’s not particularly exciting, but considering Informa’s track record of dividend growth, I think it’s worth trading off the low yield for the dividend’s long-term potential.

Rupert Hargreaves owns no share mentioned. The Motley Fool UK has recommended DS Smith. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

British coins and bank notes scattered on a surface
Investing Articles

£100 invested in a Stocks and Shares ISA today could be worth…

A Stocks and Shares ISA is a proven way of building wealth. But how much could a smaller stake of…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

April opportunities: 2 heavily-discounted stocks to consider buying

Are under-the-radar growth stocks the best place to look for potential stocks to buy as investors look for certainty in…

Read more »

Workers at Whiting refinery, US
Investing Articles

Why the BP share price *finally* surged 24.5% in March

Long-term owners of BP stock have had a frustrating few years, but is the share price rising 24.5% in March…

Read more »

Night Takeoff Of The American Space Shuttle
Investing For Beginners

Why April could be the start of a stock market recovery

Jon Smith lays out the blueprint of different catalysts that could lead to April being a solid month for a…

Read more »

Typical street lined with terraced houses and parked cars
Investing Articles

This FTSE 100 stock has fallen 50% and directors are loading up on shares

This FTSE 100 name has crashed spectacularly and company directors are snapping up shares. Clearly, these insiders expect it to…

Read more »

Mature Caucasian woman sat at a table with coffee and laptop while making notes on paper
Investing Articles

I like Rolls-Royce shares but not the price tag. Here are 2 cheaper alternatives

Rolls-Royce is an incredible company but its shares are richly valued. So are there alternative stocks offering exposure to its…

Read more »

Young Caucasian man making doubtful face at camera
Investing Articles

Should I buy Lloyds shares before the ISA deadline?

Dr James Fox takes a closer look at Lloyds' shares with the Stocks and Shares ISA deadline fast approaching. The…

Read more »

Middle aged businesswoman using laptop while working from home
Investing Articles

£10,000 invested in Nvidia stock 1 year ago is now worth…

Nvidia stock isn't just important for its shareholders. It's the bellwether for the technology sector and AI. Dr James Fox…

Read more »